1 Wright GD. Antibiotic resistance in the environment: a link to the clinic? CURR OPIN MICROBIOL. 2010;13(5):589-94. doi: 10.1016/j.mib.2010.08.005.
2 Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC INFECT DIS. 2014;14:13. doi: 10.1186/1471-2334-14-13.
3 Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N et al. Antibiotic resistance-the need for global solutions. LANCET INFECT DIS. 2013;13(12):1057-98. doi: 10.1016/S1473-3099(13)70318-9.
4 WHO. Global action Plan on Antimicrobial Resistance. 2015. https://www.who.int/phi/implementation/Marc_Sprenger_WHO.pdf. Accessed 25 Dec 2020.
5 Qiao M, Ying G, Singer AC, Zhu Y. Review of antibiotic resistance in China and its environment. ENVIRON INT. 2018;110:160-72. doi: 10.1016/j.envint.2017.10.016.
6 Zhang QQ, Ying GG, Pan CG, Liu YS, Zhao JL. Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance. ENVIRON SCI TECHNOL. 2015;49(11):6772-82. doi: 10.1021/acs.est.5b00729.
7 Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. The Lancet Infectious Diseases. 2014;14(8):742-50. doi: 10.1016/S1473-3099(14)70780-7.
8 Yin X, Song F, Gong Y, Tu X, Wang Y, Cao S et al. A systematic review of antibiotic utilization in China. J ANTIMICROB CHEMOTH. 2013;68(11):2445-52. doi: 10.1093/jac/dkt223.
9 Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China. JAMA INTERN MED. 2014;174(12):1914-20. doi: 10.1001/jamainternmed.2014.5214.
10 Kan Q, Wen J, Liu X, Li Z. Inappropriate use of antibiotics in children in China. The Lancet. 2016;387(10025):1273-4. doi: 10.1016/S0140-6736(16)30019-8.
11 Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health. 2006;2:6. doi: 10.1186/1744-8603-2-6.
12 Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China—a major future challenge. The Lancet. 2009;373(9657):30. doi: https://doi.org/10.1016/S0140-6736(08)61956-X.
13 Xiao Y, Hou F, Wang J, Yan Q, Sun Z, Lv X et al. An investigation into socio-economic impact of adverse drug reactions of antibacterial agent irrational use. Chinese Health Economics. 2010;29(05):94-6. doi: 10.3969/j.issn.1003-0743.2010.05.034.
14 General Office of the State Council. Notice on Issuing National Drug Centralized Purchasing and Using Pilot. 2019. http://www.gov.cn/zhengce/content/2019-01/17/content_5358604.htm. Accessed 25 Dec 2020.
15 Joint Purchasing Office. The results of 4+7 city drug centralized procurement. 2018. http://www.smpaa.cn/gjsdcg/2018/12/07/8531.shtml. Accessed 25 Nov 2020.
16 WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2020, Norway. 2019. http://www.whocc.no. Accessed 20 Nov 2020.
17 World Health Organization. ATC/DDD Index 2020. 2019. https://www.whocc.no/atc_ddd_index/. Accessed 23 Dec 2020.
18 Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J CLIN PHARM THER. 2002;27(4):299-309. doi: 10.1046/j.1365-2710.2002.00430.x.
19 Zhen L, Jin C, Xu HN. The impact of prescriptions audit and feedback for antibiotic use in rural clinics: interrupted time series with segmented regression analysis. BMC HEALTH SERV RES. 2018;18(1):777. doi: 10.1186/s12913-018-3602-z.
20 Li Z, Wu B, Hu M, Guo C, Chen L, Jin C. The impact of a peer review and feedback intervention on antibiotic prescribing: Interrupted time series analysis at village clinics in Qingdao, Shandong Province. Chinese Journal of Health Policy. 2013;6(10):54-9. doi: 10.3969/j.issn.1674-2982.2013.10.010.
21 Chen M, Wang Q, Shen H. Analysis on seasonal change rule of antibiotic use in our hospital. 中国药业China Pharmaceuticals. 2012;21(01):52-3. doi: 10.3969/j.issn.1006-4931.2012.01.031.
22 Mao Z, Yang Y, Chen L. Reform of Drug Supply and Guarantee System in China: Policy Measures and Effects. In: Chinese Academy of Medical Sciences, editors. Development Report on Health Reform in China (2020). Beijing: Social Sciences Academic Press; 2020.
23 People's Daily. The price of medicine has been reduced and the burden has been lightened. http://society.people.com.cn/n1/2020/0110/c1008-31542162.html. Accessed 15 Sep 2020.
24 Mao Z, Chen L, Yang Y. Great changes in the pharmaceutical industry. China Health. 2019(11):82-4
25 Tang M, He J, Chen M, Cong L, Xu Y, Yang Y et al. "4+7" city drug volume-based purchasing and using pilot program in China and its impact. Drug Discoveries & Therapeutics. 2019;13(6):365-9. doi: 10.5582/ddt.2019.01093.
26 Li R, Zhang X, Song J. Effect of Bidding of Antimicrobial Drugs on Hospital Drugs Consumption. China Pharmacy. 2009;20(1):1-4
27 Liu J, Yang D, Zhang J. Effect of the centerized bidding system of drug on the use of antibacterials in five country public hospitals in Anhui Province. Journal of Bengbu Medical College. 2016;41(4):527-30. doi: 10.13898/j.cnki.issn.1000-2200.2016.04.033.
28 General Office of the State Council. Opinions on strengthening the performance appraisal of tertiary public hospitals. 2019. http://www.gov.cn/zhengce/content/2019-01/30/content_5362266.htm. Accessed 10 Sep 2020.
29 Hao M, Wang H, Luo N, Jiang B. The normalization system of national centralized purchasing is gradually mature and clear. China Health. 2020(06):79-81. doi: 10.15973/j.cnki.cn11-3708/d.2020.06.023.
30 Kwon H, Bae S, Choi S, Park S, Lee E, Park S et al. Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea. HEALTH POLICY. 2019;123(4):388-92. doi: 10.1016/j.healthpol.2018.11.002.
31 Kwon H, Hong J, Godman B, Yang B. Price cuts and drug spending in South Korea: The case of antihyperlipidemic agents. HEALTH POLICY. 2013;112(3):217-26. doi: 10.1016/j.healthpol.2013.08.011.
32 Zhen X, Lundborg CS, Sun X, Hu X, Dong H. The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis. Antibiotics (Basel, Switzerland). 2019;8(3):115. doi: 10.3390/antibiotics8030115.
33 Yang L, Shicheng Y, Chenggang J, Mengjie Y, Xuejun M, Qiqi W. Design and analysis of two groups interrupt time series. Chinese Journal of Epidemiology. 2019;40(9):1159-63. doi: 10.3760/cma.j.issn.0254-6450.2019.09.027.